VWM
TEVA icon

Valley Wealth Managers’s Teva Pharmaceuticals TEVA Stock Holding History

Valley Wealth Managers’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-665
Closed -$21K – 168
2017
Q1 		$21K Sell
665
-700
-51% -$23.9K ﹤0.01% 163
2016
Q4 		$49K Sell
1,365
-1,900
-58% -$75.9K 0.01% 138
2016
Q3 		$150K Hold
3,265
– – 0.02% 125
2016
Q2 		$164K Buy
+3,265
New +$174K 0.03% 119

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Valley Wealth Managers's TEVA Position: Q2 2017 in Review

Valley Wealth Managers sold out of Teva Pharmaceuticals (TEVA) in Q2 2017, closing a stake of 665 shares — an estimated $21K sold.

Valley Wealth Managers first reported a position in TEVA in Q2 2016 and held it in 4 quarters. The position peaked at $164K in Q2 2016. 648 funds tracked by Wall St. Rank hold TEVA as of Q2 2017.

  • Valley Wealth Managers reported no remaining Teva Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Valley Wealth Managers sold 665 Teva Pharmaceuticals shares in Q2 2017, an estimated $21K.
  • Valley Wealth Managers first reported a position in Teva Pharmaceuticals in Q2 2016 and held it in 4 quarters.
  • Valley Wealth Managers's Teva Pharmaceuticals position peaked at $164K in Q2 2016.
  • 648 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2017.

Based on Valley Wealth Managers's 13F filing for Q2 2017, filed 13 Jul 2017.